Prospective, double-blind, randomized trial of teicoplanin versus vancomycin for the therapy of vascular access-associated bacteremia caused by gram-positive pathogens |
| |
| Authors: | K. V. I. Rolston G. P. Bodey A. W. Chow |
| |
| Affiliation: | (1) The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd. (Box 47) Houston, TX 77030, USA Tel. +1-713-792-6830; Fax +1-713-794-1818 e-mail: krolston@notes.mdacc.tmc.edu, US;(2) Division of Infectious Diseases, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia, Canada, CA |
| |
| Abstract: | Received: October 7, 1998 / Accepted: August 2, 1999 |
| |
| Keywords: | Gram-positive pathogens Staphylococcus aureus Vancomycin Teicoplanin Vascular access-associated bacteremia |
| 本文献已被 ScienceDirect SpringerLink 等数据库收录！ |
|
